136 related articles for article (PubMed ID: 30055901)
1. An ethical framework for the creation, governance and evaluation of accelerated access programs.
Pace J; Ghinea N; Kerridge I; Lipworth W
Health Policy; 2018 Sep; 122(9):984-990. PubMed ID: 30055901
[TBL] [Abstract][Full Text] [Related]
2. Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs.
Bunnik EM; Aarts N; van de Vathorst S
Health Policy; 2018 Sep; 122(9):977-983. PubMed ID: 29935731
[TBL] [Abstract][Full Text] [Related]
3. Accelerated Access to Medicines: An Ethical Analysis.
Pace J; Ghinea N; Kerridge I; Lipworth W
Ther Innov Regul Sci; 2017 Mar; 51(2):157-163. PubMed ID: 30231715
[TBL] [Abstract][Full Text] [Related]
4. Dilemmas in the compassionate supply of investigational cancer drugs.
Lewis JR; Lipworth W; Kerridge I; Doran E
Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421
[TBL] [Abstract][Full Text] [Related]
5. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
6. Access to 'investigational' cancer drugs: perspective of a trainee.
Kuo JC
Intern Med J; 2015 Feb; 45(2):235. PubMed ID: 25650544
[No Abstract] [Full Text] [Related]
7. Should patients in need be given access to experimental drugs?
Caplan AL; Bateman-House A
Expert Opin Pharmacother; 2015 Jun; 16(9):1275-9. PubMed ID: 26001178
[TBL] [Abstract][Full Text] [Related]
8. Ethical concerns regarding private equity in Right to Try in the USA.
Lee SW; Hurst DJ
Lancet Oncol; 2020 Oct; 21(10):1260-1262. PubMed ID: 33002434
[No Abstract] [Full Text] [Related]
9. Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials.
Caplan AL; Teagarden JR; Kearns L; Bateman-House AS; Mitchell E; Arawi T; Upshur R; Singh I; Rozynska J; Cwik V; Gardner SL
J Med Ethics; 2018 Nov; 44(11):761-767. PubMed ID: 29982174
[TBL] [Abstract][Full Text] [Related]
10. An analysis of common ethical justifications for compassionate use programs for experimental drugs.
Raus K
BMC Med Ethics; 2016 Oct; 17(1):60. PubMed ID: 27756370
[TBL] [Abstract][Full Text] [Related]
11. The Practice of Pharmaceutics and the Obligation to Expand Access to Investigational Drugs.
Buckley M; O'neil C
J Med Philos; 2020 Mar; 45(2):193-211. PubMed ID: 31885051
[TBL] [Abstract][Full Text] [Related]
12. Physicians' attitudes towards accelerated access to medicines.
Pace J; Kerridge I; Pearson S; Lipworth W
Health Econ Policy Law; 2021 Apr; 16(2):154-169. PubMed ID: 31668160
[TBL] [Abstract][Full Text] [Related]
13. Free to Choose: A Moral Defense of the Right-to-Try Movement.
Brodrick M
J Med Philos; 2020 Jan; 45(1):61-85. PubMed ID: 31922578
[TBL] [Abstract][Full Text] [Related]
14. Experimental countermeasures against Ebola virus: current progress and an ethical conundrum.
Plummer FA; Wong G; Kobinger GP
CMAJ; 2014 Oct; 186(15):1129-30. PubMed ID: 25139506
[No Abstract] [Full Text] [Related]
15. Formulating an Ethics of Pharmaceutical Disinvestment.
Pace J; Laba TL; Nisingizwe MP; Lipworth W
J Bioeth Inq; 2020 Mar; 17(1):75-86. PubMed ID: 32130652
[TBL] [Abstract][Full Text] [Related]
16. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
17. What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.
Bunnik EM; Aarts N
BMC Med Ethics; 2019 Nov; 20(1):80. PubMed ID: 31706313
[TBL] [Abstract][Full Text] [Related]
18. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
19. The status of paediatric medicines initiatives around the world--What has happened and what has not?
Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
[TBL] [Abstract][Full Text] [Related]
20. Expanded access to investigational drugs in psychiatry: A systematic review.
Vermeulen SF; Polak TB; Bunnik EM
Psychiatry Res; 2023 Nov; 329():115554. PubMed ID: 37890403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
